Journal becomes “victim of an organized rogue editor network”

We’re not accustomed to seeing journal article titles that end in exclamation points. But that’s what a title did earlier this month: “The Journal of Nanoparticle Research victim of an organized rogue editor network!

The journal, a Springer Nature title, wrote the editors, “has been attacked in a new way by a sophisticated and organized network.” (It turns out not to be entirely new, but more on that in a moment.) As the editors explain:

Continue reading Journal becomes “victim of an organized rogue editor network”

Weekend reads: The backstory of a Nature retraction; an author salutes her favorite review of 2020; vaping-COVID-19 link questioned

Welcome to the first Weekend Reads of 2021. Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 72.

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: The backstory of a Nature retraction; an author salutes her favorite review of 2020; vaping-COVID-19 link questioned

A look back at retraction news in 2020 — and ahead to 2021

Like everyone else, it seems, we here at Retraction Watch are more than ready to put 2020 to bed. It was a bittersweet year to celebrate our tenth anniversary and reflect on what we’ve learned. But the work never stops, so as we’ve done every year since 2010, we’ll take a look at the most notable retractions of the last 12 months, and review some important milestones and events. 

Given that journals retracted more than 1,800 papers in 2020, we had plenty of stories from which to choose. However, leading the list would have to be the papers about the pandemic that were pulled for flaws ranging from problematic data to shaky science to absolute wackiness. Indeed, if Covid were an author, it would be fifth on our leaderboard, with 72 so far. We’re certain that’s not the high-water mark for Covid retractions given the haste with which scientists have churned out papers about the disease and the virus behind it.

The intersection of politics and science drew particular attention, such as this paper about race and police killings whose authors triggered an outcry from the right after they called for their work to be retracted. Some journals engaged in an exercise of cupboard cleaning, retracting papers offensive to minorities, women and other groups. As we argued in Wired, critics of this “purging” tended to miss the larger point: the papers deserved to be retracted not just because of their repellent content but because they were scientifically unsound. And best practices for retraction recommend that they not disappear down a “memory hole,” but that they remain online, but marked “RETRACTED.”

Continue reading A look back at retraction news in 2020 — and ahead to 2021

List of retracted COVID-19 papers grows past 70

As Retraction Watch readers may know, as part of keeping our database of retractions up to date, we’ve been publishing a running list of COVID-19 papers that have been retracted. That list has been steadily growing since the end of April, but yesterday the number jumped from 45 to 72, so we thought we’d walk through where the additional retractions came from.

Ten of the new retractions are from one publisher — Elsevier — and for one reason: Elsevier screwed up. How? Well, they published these ten papers twice. The error has nothing at all to do with the authors or the quality of the work, according to the notices. We’ve commented on this phenomenon before

Continue reading List of retracted COVID-19 papers grows past 70

Weekend reads: $1.5 million payout after failure to disclose conflicts; systematic review retractions; entire class penalized for cheating

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a year-ed tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 40.

Here’s what was happening elsewhere:

Continue reading Weekend reads: $1.5 million payout after failure to disclose conflicts; systematic review retractions; entire class penalized for cheating

Nature Communications retracts much-criticized paper on mentorship

A month after announcing it would be conducting a “priority” investigation into a November 17 paper that claimed women in science fare better with male rather than female mentors, Nature Communications has retracted the article.

In the article, “The association between early career informal mentorship in academic collaborations and junior author performance,” the authors — a trio from New York University’s campus in Abu Dhabi — write that “While current diversity policies encourage same-gender mentorships to retain women in academia, our findings raise the possibility that opposite-gender mentorship may actually increase the impact of women who pursue a scientific career.” It drew nearly immediate criticism, for example:

On November 19, the journal added an editor’s note saying it would be looking into these criticisms, and today, the article was retracted following review by three experts. The retraction notice reads, in part:

Continue reading Nature Communications retracts much-criticized paper on mentorship

Publisher retracts 14 papers by doctor who ran afoul of U.S. FDA for marketing supplements

Marty Hinz
Marty Hinz

Dove Press last week retracted 14 papers by Marty Hinz, a Minnesota doctor who caught the attention of the U.S. FDA years ago for hyping supplements sold by a company he once owned.

The 14 articles — on the use of supplements to treat conditions ranging from Crohn’s disease to Parkinson’s disease — were among 20 that the publisher slapped expressions of concern on earlier this year. The other six articles flagged in April remain under review, a spokesperson for Taylor & Francis, which owns Dove, tells Retraction Watch.

That move came two and a half years after Stephen Barrett — a U.S. physician and founder of Quackwatchalerted Dove to his concerns about Hinz’s failure to disclose conflicts of interest on the papers. Barrett says Hinz has used those papers to support claims that supplements made by Hinz’s  former company, now owned by his daughter but from which he has received royalties, are effective in treating various conditions.

Continue reading Publisher retracts 14 papers by doctor who ran afoul of U.S. FDA for marketing supplements

Weekend reads: Prof sues journal, school after demotion following retraction; researcher fired after questioning why school rejected grant; the authors who like ‘publish or perish’

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 40.

Here’s what was happening elsewhere:

Continue reading Weekend reads: Prof sues journal, school after demotion following retraction; researcher fired after questioning why school rejected grant; the authors who like ‘publish or perish’

The top retractions of 2020: Mostly, but not all, COVID-19

via Pixabay

In what has become an annual tradition, our friends at The Scientist asked us to round up what we thought were the biggest retractions of the last 12 months. Not surprisingly, the list is dominated by some of the 39 retractions we’ve seen of COVID-19 studies. But that’s not the whole list.

Head on over to see our picks.

Continue reading The top retractions of 2020: Mostly, but not all, COVID-19

Weekend reads: p-hacking the US election; an apparently fake author sinks a stock; sued for using a research tool

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 39.

Here’s what was happening elsewhere:

Continue reading Weekend reads: p-hacking the US election; an apparently fake author sinks a stock; sued for using a research tool